| Thanks to SoCalBio Weekly Update Sponsor |
Coming in June SoCalBio/Image 2000 Golf Classic
Title Sponsor
 Benefiting When: June 28, 2010Time: 10:00am - 8:30pm Where: Old Ranch Country Club, Seal Beach, California |
Cut Cost of Doing Business Through the SoCalBio's Group Purchasing Program
Featured Vendor
|
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| March 29, 2010  | |
| Featured Resource | Learn About the GAP Program at UCLA   Directed by Robert Foster, (Photo right), the Global Access Program (GAP) at the UCLA Anderson School of Management was founded in 1998 and has since worked with over 328 international technology companies in ten countries. GAP is a unique educational program that matches a team of students from the Fully Employed MBA
(FEMBA) program with existing international technology companies to develop a comprehensive business strategy that enables the companies to move to the next stage of their corporate development.... Learn how your company can benefit |
 |  |
| Upcoming SoCalBio Events | SoCalBio Executive Roundtable Discussion
Regenerative Medicine Luncheon and Discussion
(Open only to executives and managers in regenerative medicine companies)
Date: April 6, 2010
Time 11:00 am - 2:00 pm
Location: Offices of Reed Smith in Downtown Los Angeles
By Invitation Only (for more info, contact SoCalBio at scbc@socalbio.org or call 213-236-4890)
*************************************************
SoCalBio HR Symposium
Best Practices in Designing Wellness Programs
Join us to learn how to craft wellness programs to improve employee health, reduce medical claims, and guarantee a return on investment (Open only to HR professionals in medical device,
IVD, biotech and generic pharma firms)
Date: April 15, 2010
Time: 9:00 am - 1:30 pm
Location: Four Seasons Hotel in Westlake Village
By Invitation Only (for more info, contact SoCalBio at
scbc@socalbio.org or call 213-236-4890)
Join the SoCalBio HR Network on LinkedIn
*************************************************
SoCalBio Networking Forum in Los Angeles
Trends in Ophthalmology
Exploring the frontier of innovation in ophthalmic products, drugs and devices conceived and commercialized in Southern California
*************************************************
SoCalBio Regulatory Best Practice Workshop
The Shifting Paradigm in FDA Process Validation
This SoCalBio workshop focuses on the FDA's guidelines regarding Process Validation. It is designed for device and pharma regulatory affairs professionals to learn what is required to approach process validation from a life cycle perspective and incorporates modern risk management and quality systems tools and concepts. |
| |
Welcome New SoCalBio Members
| Nanogea
(Weslake Village)
 Nanogea is a
nano-bioscience company focused on commercializing a sensitive single molecular detection platform based on its NanoCone chemistry and NanoCone Enabled Atomic Force technology.. Learn more
 Arrowhead Research Corporation is a holding company that forms, acquires, and operates portfolio companies commercializing innovative
nanotechnologies. By working closely with leading scientists and universities, Arrowhead identifies the latest advances in nanotechnology and matches them with product development opportunities in high-growth markets... Learn more
 Eichleay Engineers Inc. of California and Eichleay Engineers Inc. of Southern California offer a broad range of engineering, procurement, project management, and client staff augmentation services to the life science, high technology, petroleum refining, chemical, food and beverage, and manufacturing industries... Learn More
 RCRI was founded in 1999 and has become one of the nation's largest contract research organizations
(CROs) assisting medical device, biologics, and in vitro diagnostic medical product firms obtain market releases from regulatory authorities. RCRI was one of the first CROs to obtain ISO 9001:2000 certification to provide expertise in regulatory affairs, clinical trial design and management, reimbursement strategies, health economics, quality systems,
Biostatistics, and venture capital due-diligence... Learn more |
| Health Trends | Prevalence of Obesity and Diabetes in the U.S. at the County Level
According to data from the Center for Disease Control
(CDC), wide sections of the Southeast, Appalachia, and some tribal lands in the West and Northern Plains have the nation's highest rates of obesity and diabetes. In many counties in those regions, rates of diagnosed diabetes exceed 10 percent and obesity prevalence is more than 30 percent. Eighty-one percent of counties in the Appalachian region that includes Kentucky, Tennessee, and West Virginia have high rates of diabetes and obesity. So do three-quarters of counties in the southern region that includes Alabama, Georgia, Louisiana, Mississippi, and South Carolina..... Read more |
| Investment Trends | Rise in Obesity Makes VCs Hungry for Startups
Startups focused on treatments for metabolic disorders - one of the key contributing factors in obesity - have raised significant sums of venture capital in recent months... Read more
|
| Emerging Companies | Seeing the Little Picture: Novel Nanocoating Gives Atomic Force Microscope Users a Better Look at Individual Molecule
 Westlake Village-based Nanogea is featured in a recent article in Scientific America. This startup makes a coating of nanoscale cones that covers both the probe tip of an atomic force microscope
(AFM) and the substrate on which samples are prepared. The idea is to enable the
AFM--a high-resolution scanning device that uses a cantilever tip to measure the force between molecules--to more easily examine previously bound molecules one at a time... Read article
|
| Research Partnership | MannKind Corporation Achieves All Milestones of Research Agreement with Multiple Myeloma Research Foundation (MMRF) to Develop New Therapy
The MMRF awarded MannKind a $1 million grant through its 2007 Biotech Investment Award program to fund the development of innovative and effective treatments for multiple
myeloma, based on clearly defined milestones. The final milestone of the research agreement was achieved based on selection of an IRE-1α
(inositol-requiring enzyme-1) inhibitor for evaluation in the preclinical studies that are required to file an Investigational New Drug Application
(IND) with the U.S. Food and Drug Administration.... Read more
|
| Honors | MannKind Corporation Wins Prestigious Frost & Sullivan Entrepreneurial Company of the Year Award
In making this award, Frost & Sullivan lauded MannKind's growth strategy based on its innovative products and
technologies. MannKind's lead investigational product
AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, is a novel, ultra rapid acting mealtime insulin therapy made using the company's proprietary
Technosphere® formulation technology. The Technosphere technology can be applied to a wide range of drug delivery challenges and therapeutic areas, thus providing the company with a versatile asset for drug development... Read more
|
| Personnel | Response Genetics Announces Resignation of CFO
Thomas Stankovich has resigned from his position as chief financial officer of the Los Angeles-based molecular diagnostics company to pursue other interests, effective April 2, 2010. Company will commence search for replacement... Read more Cynvenio Biosystems Appoints David Sauvageau as VP Engineering & Product Development and Paul Dempsey as VP BioEngineering Research & Development
"We are very pleased to have Dave and Paul on our team," said André de Fusco, Cynvenio's president and chief executive officer. "Dave brings extensive hands-on engineering and production experience to Cynvenio and he will lead our platform and consumables development. Paul will lead our fast-growing bioengineering efforts with a special emphasis on circulating tumor cell and stem cell assay development. He will also manage Cynvenio's new labs in Westlake Village and Los Angeles, California.... Read more
Cameron Health, Inc. Appoints Kevin Hykes President and Chief Executive Officer
"We are pleased to have Kevin joining the Cameron Health team at this critical juncture in our company's development," says Dr. William Link, Chairman of the Board at Cameron Health and Managing Director at Versant Ventures. "Cameron Health is making a very important transition from a development-stage organization to a company focused on the commercialization of the
S-ICD System. Kevin's leadership capabilities, coupled with his knowledge of the ICD market, are critical to accelerating the growth of Cameron Health" .... Read more
Eichleay Announces the Addition of Stephania Armani to the Growing Staff of its Southern California Operations
Stephania Armani, Ph.D., has over twenty-five years of architectural design experience working on biotechnology, pharmaceutical, microelectronics, and advanced technology projects. Her background encompasses everything from the renovation and expansion of existing facilities to the construction of new buildings. She will contribute to Eichleay's success by managing and supporting our multidiscipline design teams in the manufacturing markets that we serve... Learn more
|
| Jobs Available | Cameron Health, Inc.
(San
Clemente) |
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
